Human tissue distribution of caspofungin.

Tissue concentrations of caspofungin were determined in nine clinically relevant tissues taken during routine autopsy of 20 patients who had died during caspofungin treatment or within 23 days of cessation. The highest levels were achieved in liver, with concentrations ranging from ≤0.50 to 91.5 µg/g (0.60 µg/g 21 days after the last administration), followed by spleen (<0.25-46.3 µg/g), kidney (<0.25-33.6 µg/g) and lung (<0.25-31.0 µg/g). Intermediate concentrations were found in pancreas, skeletal muscle, thyroid and myocardium. The lowest concentrations were found in brain; caspofungin was only detectable in six of 17 samples. Caspofungin concentrations exceeded the minimum inhibitory concentration values of pathogenic Candida spp. in most of the tissue samples taken from patients who had died during treatment, except in brain samples. These findings warrant clinical outcome studies to establish the optimal treatment for deep-seated candidiasis, and support the current recommendations against echinocandins for treatment of fungal meningoencephalitis. Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Citation

Jana Marx, Vera Reinstadler, Tiziana Gasperetti, René Welte, Herbert Oberacher, Patrizia Moser, Michael Joannidis, Romuald Bellmann. Human tissue distribution of caspofungin. International journal of antimicrobial agents. 2022 Apr;59(4):106553

Mesh Tags

Substances

PMID: 35176477

search → result